| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | 4.75e-09 | 694 | 19 | 9 | GO:0003729 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.54e-07 | 276 | 19 | 6 | GO:0003730 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 8.19e-06 | 42 | 19 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 5.95e-05 | 1160 | 19 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.52e-04 | 111 | 19 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.60e-04 | 1356 | 19 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 1.67e-03 | 64 | 19 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.72e-03 | 562 | 19 | 4 | GO:0003712 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 2.47e-03 | 78 | 19 | 2 | GO:0003725 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | TRA2A CAPRIN1 TAF15 A1CF HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPR | 1.47e-12 | 443 | 19 | 10 | GO:1903311 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | TRA2A CAPRIN1 TAF15 HNRNPH3 A1CF HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.10e-12 | 917 | 19 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA splicing | TRA2A TAF15 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 5.06e-12 | 502 | 19 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | RNA processing | DDX21 TRA2A TAF15 HNRNPH3 A1CF HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 6.54e-10 | 1500 | 19 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 6.83e-09 | 309 | 19 | 7 | GO:0061013 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.32e-08 | 87 | 19 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.44e-08 | 551 | 19 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.88e-08 | 358 | 19 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.88e-08 | 358 | 19 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.03e-08 | 362 | 19 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.50e-08 | 373 | 19 | 7 | GO:0006402 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.81e-08 | 101 | 19 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.39e-08 | 115 | 19 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 6.83e-08 | 432 | 19 | 7 | GO:0006401 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.11e-07 | 464 | 19 | 7 | GO:0141188 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.78e-07 | 292 | 19 | 6 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 2.43e-07 | 308 | 19 | 6 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.01e-06 | 207 | 19 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 1.71e-06 | 696 | 19 | 7 | GO:0034655 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 3.02e-06 | 259 | 19 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 2.15e-05 | 1446 | 19 | 8 | GO:0010628 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.88e-05 | 9 | 19 | 2 | GO:2000623 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 3.07e-05 | 418 | 19 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 3.33e-05 | 206 | 19 | 4 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 3.66e-05 | 211 | 19 | 4 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 3.66e-05 | 211 | 19 | 4 | GO:0061014 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 4.64e-05 | 77 | 19 | 3 | GO:0048255 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 4.66e-05 | 1153 | 19 | 7 | GO:0010608 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 5.01e-05 | 79 | 19 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 6.92e-05 | 88 | 19 | 3 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.27e-05 | 14 | 19 | 2 | GO:2000622 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 7.88e-05 | 1252 | 19 | 7 | GO:0009894 | |
| GeneOntologyBiologicalProcess | intracellular mRNA localization | 1.22e-04 | 18 | 19 | 2 | GO:0008298 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.15e-04 | 129 | 19 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 2.30e-04 | 132 | 19 | 3 | GO:0000956 | |
| GeneOntologyBiologicalProcess | mRNA modification | 2.58e-04 | 26 | 19 | 2 | GO:0016556 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 3.91e-04 | 158 | 19 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 4.97e-04 | 36 | 19 | 2 | GO:0034063 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 8.12e-04 | 46 | 19 | 2 | GO:0000184 | |
| GeneOntologyBiologicalProcess | RNA localization | 9.83e-04 | 217 | 19 | 3 | GO:0006403 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 1.16e-03 | 230 | 19 | 3 | GO:0017148 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.33e-03 | 59 | 19 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.62e-03 | 65 | 19 | 2 | GO:0000288 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 3.41e-03 | 701 | 19 | 4 | GO:0009896 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.14e-06 | 215 | 19 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.36e-05 | 1377 | 19 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | mRNA editing complex | 1.64e-05 | 7 | 19 | 2 | GO:0045293 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 5.35e-05 | 1194 | 19 | 7 | GO:1990904 | |
| GeneOntologyCellularComponent | dendrite | 8.05e-05 | 858 | 19 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 8.15e-05 | 860 | 19 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 8.62e-05 | 96 | 19 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.15e-04 | 287 | 19 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 5.67e-04 | 1228 | 19 | 6 | GO:0036477 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.75e-03 | 269 | 19 | 3 | GO:0036464 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 3.46e-03 | 97 | 19 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 5.61e-03 | 817 | 19 | 4 | GO:0098978 | |
| GeneOntologyCellularComponent | presynapse | 7.46e-03 | 886 | 19 | 4 | GO:0098793 | |
| GeneOntologyCellularComponent | chromatin | 8.89e-03 | 1480 | 19 | 5 | GO:0000785 | |
| GeneOntologyCellularComponent | axon terminus | 1.53e-02 | 210 | 19 | 2 | GO:0043679 | |
| Domain | Nucleotide-bd_a/b_plait | DDX21 TRA2A TAF15 HNRNPH3 A1CF HNRNPL FUS SRSF2 SYNCRIP HNRNPR | 1.76e-14 | 258 | 19 | 10 | IPR012677 |
| Domain | RRM_1 | 1.86e-13 | 208 | 19 | 9 | PF00076 | |
| Domain | RRM | 2.73e-13 | 217 | 19 | 9 | SM00360 | |
| Domain | RRM_dom | 4.10e-13 | 227 | 19 | 9 | IPR000504 | |
| Domain | RRM | 4.62e-13 | 230 | 19 | 9 | PS50102 | |
| Domain | - | 7.89e-13 | 244 | 19 | 9 | 3.30.70.330 | |
| Domain | HnRNP_R/Q_splicing_fac | 8.91e-09 | 5 | 19 | 3 | IPR006535 | |
| Domain | - | 4.39e-05 | 10 | 19 | 2 | 4.10.1060.10 | |
| Domain | zf-RanBP | 2.24e-04 | 22 | 19 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 2.45e-04 | 23 | 19 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 2.45e-04 | 23 | 19 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 2.67e-04 | 24 | 19 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 2.90e-04 | 25 | 19 | 2 | IPR001876 | |
| Pathway | WP_MRNA_PROCESSING | 6.28e-10 | 451 | 17 | 9 | MM15946 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.13e-05 | 724 | 17 | 7 | M16843 | |
| Pathway | WP_MRNA_PROCESSING | 1.32e-05 | 126 | 17 | 4 | M39406 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.36e-05 | 612 | 17 | 6 | MM15547 | |
| Pathway | REACTOME_MRNA_SPLICING | 8.25e-05 | 201 | 17 | 4 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.01e-04 | 212 | 17 | 4 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.84e-04 | 277 | 17 | 4 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.08e-04 | 283 | 17 | 4 | M13087 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | DDX21 CAPRIN1 BCLAF1 PRRC2C HNRNPH3 A1CF HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPR | 3.96e-24 | 258 | 19 | 13 | 37794589 |
| Pubmed | DDX21 CAPRIN1 BCLAF1 PRRC2C KRT77 TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 5.76e-22 | 551 | 19 | 14 | 34728620 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 9.52e-22 | 807 | 19 | 15 | 22681889 |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.16e-20 | 713 | 19 | 14 | 29802200 | |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPUL1 HNRNPR | 1.16e-19 | 244 | 19 | 11 | 29884807 | |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 2.36e-19 | 260 | 19 | 11 | 36199071 | |
| Pubmed | DDX21 TRA2A CAPRIN1 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.95e-19 | 421 | 19 | 12 | 34650049 | |
| Pubmed | DDX21 CAPRIN1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.05e-18 | 725 | 19 | 13 | 27025967 | |
| Pubmed | DDX21 TRA2A CAPRIN1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.78e-17 | 615 | 19 | 12 | 31048545 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPUL1 HNRNPR | 6.28e-17 | 430 | 19 | 11 | 38172120 |
| Pubmed | DDX21 CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 6.78e-17 | 274 | 19 | 10 | 34244482 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | DDX21 CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.22e-16 | 678 | 19 | 12 | 30209976 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.70e-16 | 989 | 19 | 13 | 36424410 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX21 TRA2A BCLAF1 KRT77 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.67e-16 | 1024 | 19 | 13 | 24711643 |
| Pubmed | 7.61e-16 | 114 | 19 | 8 | 31553912 | ||
| Pubmed | 1.53e-15 | 8 | 19 | 5 | 12183049 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DDX21 CAPRIN1 BCLAF1 PRRC2C KRT77 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPR | 2.69e-15 | 605 | 19 | 11 | 28977666 |
| Pubmed | 3.20e-15 | 245 | 19 | 9 | 35652658 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C KRT77 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 3.75e-15 | 1257 | 19 | 13 | 36526897 |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.44e-15 | 254 | 19 | 9 | 28431233 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 6.10e-15 | 147 | 19 | 8 | 28977470 | |
| Pubmed | DDX21 CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 6.41e-15 | 655 | 19 | 11 | 35819319 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DDX21 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 7.16e-15 | 954 | 19 | 12 | 36373674 |
| Pubmed | TRA2A CAPRIN1 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPR | 8.10e-15 | 441 | 19 | 10 | 31239290 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | DDX21 TRA2A CAPRIN1 PRRC2C HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 | 1.29e-14 | 462 | 19 | 10 | 31138677 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DDX21 TRA2A BCLAF1 PRRC2C HNRNPH3 HNRNPL FXR1 SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.65e-14 | 714 | 19 | 11 | 28302793 |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | DDX21 CAPRIN1 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.89e-14 | 480 | 19 | 10 | 25437307 |
| Pubmed | DDX21 TRA2A BCLAF1 PRRC2C HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.13e-14 | 731 | 19 | 11 | 29298432 | |
| Pubmed | 3.01e-14 | 90 | 19 | 7 | 23151878 | ||
| Pubmed | DDX21 TRA2A CAPRIN1 KRT77 TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 6.77e-14 | 1153 | 19 | 12 | 29845934 | |
| Pubmed | 7.47e-14 | 347 | 19 | 9 | 16033648 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | CAPRIN1 BCLAF1 PRRC2C KRT77 HNRNPL FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 8.47e-14 | 558 | 19 | 10 | 27591049 |
| Pubmed | DDX21 CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.71e-13 | 1247 | 19 | 12 | 27684187 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX21 CAPRIN1 BCLAF1 KRT77 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.42e-13 | 1284 | 19 | 12 | 17353931 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TRA2A CAPRIN1 BCLAF1 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.65e-13 | 626 | 19 | 10 | 33644029 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX21 TRA2A TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.29e-13 | 1318 | 19 | 12 | 30463901 |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS HNRNPUL1 HNRNPR | 4.48e-13 | 660 | 19 | 10 | 32780723 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX21 CAPRIN1 PRRC2C HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 7.60e-13 | 1415 | 19 | 12 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX21 TRA2A CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 8.26e-13 | 1425 | 19 | 12 | 30948266 |
| Pubmed | DDX21 CAPRIN1 BCLAF1 TAF15 HNRNPL FXR1 FUS FAM98B SYNCRIP HNRNPR | 9.37e-13 | 711 | 19 | 10 | 33022573 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DDX21 CAPRIN1 BCLAF1 PRRC2C FXR1 FAM98B SRSF2 SYNCRIP HNRNPR | 1.54e-12 | 486 | 19 | 9 | 30940648 |
| Pubmed | DDX21 CAPRIN1 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPUL1 HNRNPR | 1.78e-12 | 494 | 19 | 9 | 26831064 | |
| Pubmed | 1.84e-12 | 298 | 19 | 8 | 30737378 | ||
| Pubmed | DDX21 TRA2A CAPRIN1 KRT77 HNRNPH3 HNRNPL FXR1 SRSF2 SYNCRIP HNRNPR | 3.12e-12 | 803 | 19 | 10 | 36517590 | |
| Pubmed | DDX21 CAPRIN1 TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.36e-12 | 809 | 19 | 10 | 32129710 | |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPL FXR1 FUS SRSF2 HNRNPR | 5.27e-12 | 847 | 19 | 10 | 35850772 | |
| Pubmed | 6.08e-12 | 346 | 19 | 8 | 25324306 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX21 TRA2A BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.04e-11 | 1294 | 19 | 11 | 30804502 |
| Pubmed | 1.10e-11 | 206 | 19 | 7 | 22174317 | ||
| Pubmed | DDX21 CAPRIN1 PRRC2C HNRNPH3 HNRNPL FXR1 FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 1.46e-11 | 1335 | 19 | 11 | 29229926 | |
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FAM98B | 1.82e-11 | 641 | 19 | 9 | 36057605 | |
| Pubmed | 1.89e-11 | 399 | 19 | 8 | 35987950 | ||
| Pubmed | 1.91e-11 | 223 | 19 | 7 | 20020773 | ||
| Pubmed | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C KRT77 TAF15 A1CF FXR1 FAM98B SRSF2 | 1.94e-11 | 1371 | 19 | 11 | 36244648 | |
| Pubmed | DDX21 BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPUL1 HNRNPR | 2.12e-11 | 652 | 19 | 9 | 31180492 | |
| Pubmed | 2.14e-11 | 653 | 19 | 9 | 22586326 | ||
| Pubmed | 2.16e-11 | 109 | 19 | 6 | 29511296 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | DDX21 CAPRIN1 BCLAF1 PRRC2C HNRNPL FXR1 FAM98B SRSF2 SYNCRIP | 2.52e-11 | 665 | 19 | 9 | 30457570 |
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 3.31e-11 | 45 | 19 | 5 | 25496916 | |
| Pubmed | 3.70e-11 | 245 | 19 | 7 | 21182205 | ||
| Pubmed | 4.09e-11 | 121 | 19 | 6 | 34029587 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX21 TRA2A BCLAF1 TAF15 HNRNPH3 HNRNPL SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 5.84e-11 | 1082 | 19 | 10 | 38697112 |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 6.33e-11 | 130 | 19 | 6 | 32905556 | |
| Pubmed | 6.84e-11 | 469 | 19 | 8 | 37314180 | ||
| Pubmed | 7.02e-11 | 52 | 19 | 5 | 26265008 | ||
| Pubmed | 8.32e-11 | 136 | 19 | 6 | 26979993 | ||
| Pubmed | 8.32e-11 | 136 | 19 | 6 | 21280222 | ||
| Pubmed | 9.09e-11 | 138 | 19 | 6 | 30320910 | ||
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.13e-10 | 57 | 19 | 5 | 17932509 | |
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 1.38e-10 | 3 | 19 | 3 | 30755280 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 2.40e-10 | 162 | 19 | 6 | 31363146 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX21 TRA2A TAF15 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 2.52e-10 | 1257 | 19 | 10 | 37317656 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.97e-10 | 330 | 19 | 7 | 33301849 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 3.16e-10 | 333 | 19 | 7 | 32665550 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 3.37e-10 | 336 | 19 | 7 | 31253590 | |
| Pubmed | 3.45e-10 | 172 | 19 | 6 | 26336360 | ||
| Pubmed | 3.66e-10 | 340 | 19 | 7 | 24332808 | ||
| Pubmed | 4.85e-10 | 601 | 19 | 8 | 33658012 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX21 CAPRIN1 BCLAF1 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 5.84e-10 | 949 | 19 | 9 | 36574265 |
| Pubmed | 7.14e-10 | 971 | 19 | 9 | 33306668 | ||
| Pubmed | 7.77e-10 | 638 | 19 | 8 | 33239621 | ||
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 9.35e-10 | 203 | 19 | 6 | 24244333 | |
| Pubmed | DDX21 BCLAF1 PRRC2C KRT77 TAF15 FXR1 FUS FAM98B SYNCRIP HNRNPR | 9.55e-10 | 1442 | 19 | 10 | 35575683 | |
| Pubmed | 1.05e-09 | 88 | 19 | 5 | 26318153 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.11e-09 | 89 | 19 | 5 | 22446626 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 1.13e-09 | 400 | 19 | 7 | 35013556 | |
| Pubmed | 1.17e-09 | 90 | 19 | 5 | 33087562 | ||
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 1.29e-09 | 28 | 19 | 4 | 20975687 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DDX21 TRA2A CAPRIN1 KRT77 HNRNPH3 HNRNPL FXR1 SYNCRIP HNRNPUL1 HNRNPR | 1.36e-09 | 1496 | 19 | 10 | 32877691 |
| Pubmed | 1.72e-09 | 425 | 19 | 7 | 21081503 | ||
| Pubmed | CAPRIN1 BCLAF1 PRRC2C HNRNPL FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 2.18e-09 | 1103 | 19 | 9 | 34189442 | |
| Pubmed | 2.31e-09 | 236 | 19 | 6 | 36339263 | ||
| Pubmed | 2.49e-09 | 239 | 19 | 6 | 26641092 | ||
| Pubmed | 3.09e-09 | 109 | 19 | 5 | 12226669 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CAPRIN1 PRRC2C HNRNPL FXR1 FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 3.12e-09 | 1149 | 19 | 9 | 35446349 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DDX21 CAPRIN1 BCLAF1 TAF15 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.26e-09 | 1155 | 19 | 9 | 20360068 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.82e-09 | 477 | 19 | 7 | 31300519 | |
| Pubmed | 4.06e-09 | 115 | 19 | 5 | 17332742 | ||
| Pubmed | 4.66e-09 | 491 | 19 | 7 | 22623428 | ||
| Pubmed | 5.47e-09 | 122 | 19 | 5 | 29530978 | ||
| Interaction | MIR138-1 interactions | 2.94e-18 | 68 | 19 | 9 | int:MIR138-1 | |
| Interaction | MIR7-3 interactions | 8.47e-18 | 76 | 19 | 9 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 8.47e-18 | 76 | 19 | 9 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 8.47e-18 | 76 | 19 | 9 | int:MIR199A2 | |
| Interaction | MIR222 interactions | 1.22e-17 | 79 | 19 | 9 | int:MIR222 | |
| Interaction | MIR200B interactions | 2.18e-17 | 84 | 19 | 9 | int:MIR200B | |
| Interaction | MIR9-1 interactions | 2.44e-17 | 85 | 19 | 9 | int:MIR9-1 | |
| Interaction | MIR200C interactions | 4.63e-17 | 91 | 19 | 9 | int:MIR200C | |
| Interaction | MIR205 interactions | 5.67e-17 | 93 | 19 | 9 | int:MIR205 | |
| Interaction | MIRLET7F1 interactions | 6.27e-17 | 94 | 19 | 9 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 7.64e-17 | 96 | 19 | 9 | int:MIRLET7A2 | |
| Interaction | MYCN interactions | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C KRT77 TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.58e-16 | 1373 | 19 | 16 | int:MYCN |
| Interaction | MIR34A interactions | 1.61e-16 | 104 | 19 | 9 | int:MIR34A | |
| Interaction | MIRLET7E interactions | 1.93e-16 | 106 | 19 | 9 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 2.29e-16 | 108 | 19 | 9 | int:MIRLET7A1 | |
| Interaction | MIRLET7G interactions | 4.82e-16 | 117 | 19 | 9 | int:MIRLET7G | |
| Interaction | TRIM31 interactions | DDX21 TRA2A CAPRIN1 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 6.46e-16 | 454 | 19 | 12 | int:TRIM31 |
| Interaction | MIR140 interactions | 1.16e-15 | 71 | 19 | 8 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.16e-15 | 71 | 19 | 8 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.16e-15 | 71 | 19 | 8 | int:MIR29B2 | |
| Interaction | SNRPA interactions | DDX21 TRA2A BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.32e-15 | 482 | 19 | 12 | int:SNRPA |
| Interaction | MIR18A interactions | 1.46e-15 | 73 | 19 | 8 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 1.46e-15 | 73 | 19 | 8 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 1.64e-15 | 74 | 19 | 8 | int:MIR20A | |
| Interaction | PRMT1 interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C KRT77 TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SYNCRIP HNRNPUL1 HNRNPR | 1.67e-15 | 929 | 19 | 14 | int:PRMT1 |
| Interaction | MIR15A interactions | 1.83e-15 | 75 | 19 | 8 | int:MIR15A | |
| Interaction | MIR429 interactions | 2.05e-15 | 76 | 19 | 8 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 2.28e-15 | 77 | 19 | 8 | int:MIR9-2 | |
| Interaction | MIR92A1 interactions | 2.54e-15 | 78 | 19 | 8 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 2.54e-15 | 78 | 19 | 8 | int:MIR98 | |
| Interaction | MIR451A interactions | 2.54e-15 | 78 | 19 | 8 | int:MIR451A | |
| Interaction | MIR206 interactions | 2.83e-15 | 79 | 19 | 8 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 2.83e-15 | 79 | 19 | 8 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 2.83e-15 | 79 | 19 | 8 | int:MIR34C | |
| Interaction | MIR143 interactions | 3.14e-15 | 80 | 19 | 8 | int:MIR143 | |
| Interaction | MIR145 interactions | 3.48e-15 | 81 | 19 | 8 | int:MIR145 | |
| Interaction | SNRNP70 interactions | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.70e-15 | 984 | 19 | 14 | int:SNRNP70 |
| Interaction | MIR10B interactions | 3.86e-15 | 82 | 19 | 8 | int:MIR10B | |
| Interaction | MIR106A interactions | 4.27e-15 | 83 | 19 | 8 | int:MIR106A | |
| Interaction | MIR31 interactions | 4.71e-15 | 84 | 19 | 8 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 4.71e-15 | 84 | 19 | 8 | int:MIR7-2 | |
| Interaction | MIR199A1 interactions | 4.71e-15 | 84 | 19 | 8 | int:MIR199A1 | |
| Interaction | MIR107 interactions | 5.20e-15 | 85 | 19 | 8 | int:MIR107 | |
| Interaction | MIR17 interactions | 5.20e-15 | 85 | 19 | 8 | int:MIR17 | |
| Interaction | MIR18B interactions | 5.20e-15 | 85 | 19 | 8 | int:MIR18B | |
| Interaction | MIR93 interactions | 5.20e-15 | 85 | 19 | 8 | int:MIR93 | |
| Interaction | MIR16-2 interactions | 5.20e-15 | 85 | 19 | 8 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 5.73e-15 | 86 | 19 | 8 | int:MIR20B | |
| Interaction | MIR141 interactions | 6.93e-15 | 88 | 19 | 8 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 6.93e-15 | 88 | 19 | 8 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 7.62e-15 | 89 | 19 | 8 | int:MIR29C | |
| Interaction | MIR221 interactions | 8.35e-15 | 90 | 19 | 8 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 8.35e-15 | 90 | 19 | 8 | int:MIR1-1 | |
| Interaction | MIR155 interactions | 1.00e-14 | 92 | 19 | 8 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 1.00e-14 | 92 | 19 | 8 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 1.10e-14 | 93 | 19 | 8 | int:MIR214 | |
| Interaction | MIRLET7C interactions | 1.55e-14 | 97 | 19 | 8 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 1.55e-14 | 97 | 19 | 8 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.55e-14 | 97 | 19 | 8 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 1.55e-14 | 97 | 19 | 8 | int:MIR363 | |
| Interaction | MIR106B interactions | 1.69e-14 | 98 | 19 | 8 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 1.84e-14 | 99 | 19 | 8 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 2.00e-14 | 100 | 19 | 8 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 2.17e-14 | 101 | 19 | 8 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 2.17e-14 | 101 | 19 | 8 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 2.17e-14 | 101 | 19 | 8 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 2.35e-14 | 102 | 19 | 8 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 2.55e-14 | 103 | 19 | 8 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 2.55e-14 | 103 | 19 | 8 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 2.76e-14 | 104 | 19 | 8 | int:MIR19B1 | |
| Interaction | PRMT8 interactions | 2.76e-14 | 104 | 19 | 8 | int:PRMT8 | |
| Interaction | MIR34B interactions | 4.37e-14 | 110 | 19 | 8 | int:MIR34B | |
| Interaction | MIRLET7I interactions | 5.86e-14 | 114 | 19 | 8 | int:MIRLET7I | |
| Interaction | RC3H2 interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 6.39e-14 | 667 | 19 | 12 | int:RC3H2 |
| Interaction | GLDC interactions | DDX21 CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 7.44e-14 | 321 | 19 | 10 | int:GLDC |
| Interaction | PRC1 interactions | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.48e-13 | 973 | 19 | 13 | int:PRC1 |
| Interaction | SRSF9 interactions | 1.85e-13 | 224 | 19 | 9 | int:SRSF9 | |
| Interaction | MIR9-3 interactions | 2.18e-13 | 70 | 19 | 7 | int:MIR9-3 | |
| Interaction | HNRNPDL interactions | DDX21 PRRC2C TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.61e-13 | 364 | 19 | 10 | int:HNRNPDL |
| Interaction | FUS interactions | DDX21 TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.87e-13 | 757 | 19 | 12 | int:FUS |
| Interaction | CHD3 interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C HIC1 KRT77 TAF15 HNRNPH3 HNRNPL FUS SYNCRIP HNRNPR | 2.87e-13 | 757 | 19 | 12 | int:CHD3 |
| Interaction | UFL1 interactions | DDX21 TRA2A CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.11e-13 | 1031 | 19 | 13 | int:UFL1 |
| Interaction | RBM39 interactions | DDX21 TRA2A BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.56e-13 | 1042 | 19 | 13 | int:RBM39 |
| Interaction | MIR200A interactions | 4.37e-13 | 77 | 19 | 7 | int:MIR200A | |
| Interaction | CIT interactions | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 7.75e-13 | 1450 | 19 | 14 | int:CIT |
| Interaction | PHB1 interactions | DDX21 CAPRIN1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 9.26e-13 | 1123 | 19 | 13 | int:PHB1 |
| Interaction | WWP2 interactions | DDX21 TRA2A CAPRIN1 PRRC2C TAF15 HNRNPH3 HNRNPL FXR1 SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 9.80e-13 | 840 | 19 | 12 | int:WWP2 |
| Interaction | MIR29A interactions | 1.06e-12 | 87 | 19 | 7 | int:MIR29A | |
| Interaction | MIR92A2 interactions | 1.35e-12 | 90 | 19 | 7 | int:MIR92A2 | |
| Interaction | ZC3H18 interactions | DDX21 TRA2A BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 1.63e-12 | 877 | 19 | 12 | int:ZC3H18 |
| Interaction | MIR19B2 interactions | 1.84e-12 | 94 | 19 | 7 | int:MIR19B2 | |
| Interaction | CAND1 interactions | CAPRIN1 BCLAF1 TAF15 HNRNPH3 HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.04e-12 | 894 | 19 | 12 | int:CAND1 |
| Interaction | OBSL1 interactions | DDX21 CACNA1B TRA2A BCLAF1 TAF15 HNRNPH3 HNRNPL FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 2.27e-12 | 902 | 19 | 12 | int:OBSL1 |
| Interaction | RC3H1 interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C HNRNPL FXR1 FUS SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.36e-12 | 677 | 19 | 11 | int:RC3H1 |
| Interaction | DDRGK1 interactions | DDX21 TRA2A CAPRIN1 BCLAF1 PRRC2C HNRNPL FXR1 FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 3.58e-12 | 1249 | 19 | 13 | int:DDRGK1 |
| Interaction | NUPR1 interactions | DDX21 TRA2A CAPRIN1 BCLAF1 HNRNPH3 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 3.69e-12 | 683 | 19 | 11 | int:NUPR1 |
| Interaction | RNF113A interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 4.26e-12 | 692 | 19 | 11 | int:RNF113A |
| Interaction | SMC5 interactions | DDX21 BCLAF1 PRRC2C TAF15 HNRNPH3 HNRNPL FUS FAM98B SRSF2 SYNCRIP HNRNPUL1 HNRNPR | 7.62e-12 | 1000 | 19 | 12 | int:SMC5 |
| Interaction | TARDBP interactions | DDX21 CAPRIN1 BCLAF1 PRRC2C TAF15 HNRNPL FUS SYNCRIP HNRNPUL1 HNRNPR | 9.00e-12 | 520 | 19 | 10 | int:TARDBP |
| Interaction | CPSF6 interactions | TRA2A CAPRIN1 BCLAF1 TAF15 HNRNPL FXR1 FUS SYNCRIP HNRNPUL1 HNRNPR | 1.01e-11 | 526 | 19 | 10 | int:CPSF6 |
| Cytoband | 19q13.2 | 2.08e-03 | 164 | 19 | 2 | 19q13.2 | |
| GeneFamily | RNA binding motif containing | 2.53e-15 | 213 | 13 | 9 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 9.95e-05 | 21 | 13 | 2 | 89 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.34e-08 | 432 | 19 | 7 | M41149 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 2.09e-08 | 734 | 19 | 8 | M3835 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 2.80e-06 | 1394 | 19 | 8 | M9585 | |
| Coexpression | FISCHER_DREAM_TARGETS | 3.15e-06 | 969 | 19 | 7 | M149 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 4.91e-06 | 363 | 19 | 5 | M41103 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 5.58e-06 | 166 | 19 | 4 | M8129 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 6.14e-06 | 170 | 19 | 4 | M6822 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 6.32e-06 | 685 | 19 | 6 | MM3782 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 8.06e-06 | 402 | 19 | 5 | M5275 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 9.40e-06 | 1144 | 19 | 7 | MM3843 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 1.15e-05 | 761 | 19 | 6 | M11961 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.17e-05 | 200 | 19 | 4 | M5926 | |
| Coexpression | BIDUS_METASTASIS_UP | 1.73e-05 | 221 | 19 | 4 | M15866 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 1.79e-05 | 474 | 19 | 5 | M40991 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | 2.07e-05 | 844 | 19 | 6 | M41129 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 2.47e-05 | 79 | 19 | 3 | M40003 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 3.19e-05 | 911 | 19 | 6 | M40038 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 3.89e-05 | 272 | 19 | 4 | MM3825 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_UP | 4.00e-05 | 561 | 19 | 5 | M1463 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 5.30e-05 | 102 | 19 | 3 | M2124 | |
| Coexpression | DER_IFN_BETA_RESPONSE_UP | 5.45e-05 | 103 | 19 | 3 | M13453 | |
| Coexpression | HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP | 9.39e-05 | 20 | 19 | 2 | M2558 | |
| Coexpression | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP | 1.04e-04 | 21 | 19 | 2 | M1593 | |
| Coexpression | HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP | 1.14e-04 | 22 | 19 | 2 | M2547 | |
| Coexpression | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP | 1.14e-04 | 22 | 19 | 2 | MM678 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | 1.22e-04 | 365 | 19 | 4 | M41711 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP | 1.76e-04 | 153 | 19 | 3 | M438 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 1.85e-04 | 776 | 19 | 5 | M1107 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.06e-04 | 794 | 19 | 5 | MM982 | |
| Coexpression | IBRAHIM_NRF1_UP | 2.08e-04 | 420 | 19 | 4 | M42509 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 2.49e-04 | 172 | 19 | 3 | M17811 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 2.53e-04 | 173 | 19 | 3 | MM580 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 2.80e-04 | 454 | 19 | 4 | M19927 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.91e-04 | 856 | 19 | 5 | M4500 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 3.04e-04 | 184 | 19 | 3 | M19988 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 3.13e-04 | 186 | 19 | 3 | M4911 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 3.51e-04 | 1407 | 19 | 6 | M14427 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_NKCELL_UP | 3.76e-04 | 198 | 19 | 3 | M5420 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN | 3.76e-04 | 198 | 19 | 3 | M7460 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_DN | 3.76e-04 | 198 | 19 | 3 | M9530 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 3.82e-04 | 199 | 19 | 3 | M7656 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 3.82e-04 | 199 | 19 | 3 | M3175 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 3.82e-04 | 199 | 19 | 3 | M6060 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 3.88e-04 | 200 | 19 | 3 | M7653 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP | 3.88e-04 | 200 | 19 | 3 | M8868 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 3.88e-04 | 200 | 19 | 3 | M6617 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 4.79e-04 | 523 | 19 | 4 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 5.18e-04 | 534 | 19 | 4 | MM1054 | |
| Coexpression | YANG_BREAST_CANCER_ESR1_LASER_DN | 5.28e-04 | 47 | 19 | 2 | M11078 | |
| Coexpression | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN | 5.50e-04 | 48 | 19 | 2 | M2138 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 5.98e-04 | 555 | 19 | 4 | M2343 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 6.53e-04 | 568 | 19 | 4 | MM3824 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 6.97e-04 | 54 | 19 | 2 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 6.97e-04 | 54 | 19 | 2 | M2372 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 7.38e-04 | 587 | 19 | 4 | M40869 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 8.63e-04 | 612 | 19 | 4 | M4772 | |
| Coexpression | BENPORATH_CYCLING_GENES | 1.07e-03 | 648 | 19 | 4 | M8156 | |
| Coexpression | MANALO_HYPOXIA_DN | 1.16e-03 | 292 | 19 | 3 | M18562 | |
| Coexpression | MUELLER_PLURINET | 1.24e-03 | 299 | 19 | 3 | M123 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.28e-03 | 680 | 19 | 4 | M41089 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C1 | 1.30e-03 | 74 | 19 | 2 | M7933 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 1.30e-03 | 304 | 19 | 3 | M39208 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 1.32e-03 | 305 | 19 | 3 | M40025 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 1.39e-03 | 311 | 19 | 3 | M40024 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 1.46e-03 | 705 | 19 | 4 | M1410 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 1.48e-03 | 79 | 19 | 2 | MM3780 | |
| Coexpression | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP | 1.56e-03 | 81 | 19 | 2 | M17082 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.60e-03 | 82 | 19 | 2 | MM3777 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 1.81e-03 | 341 | 19 | 3 | M2879 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 1.86e-03 | 344 | 19 | 3 | M2239 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | 1.87e-03 | 1290 | 19 | 5 | M80 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.48e-07 | 498 | 19 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.50e-06 | 231 | 19 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.94e-06 | 532 | 19 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 5.03e-06 | 843 | 19 | 7 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.67e-05 | 379 | 19 | 5 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 3.23e-05 | 435 | 19 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 6.74e-05 | 844 | 19 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.49e-05 | 533 | 19 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.05e-04 | 339 | 19 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.29e-04 | 349 | 19 | 4 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.01e-04 | 375 | 19 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.10e-04 | 378 | 19 | 4 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.95e-04 | 403 | 19 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 4.06e-04 | 406 | 19 | 4 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 4.15e-04 | 166 | 19 | 3 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.34e-04 | 413 | 19 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.01e-04 | 429 | 19 | 4 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 5.37e-04 | 437 | 19 | 4 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 5.45e-04 | 795 | 19 | 5 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.64e-04 | 801 | 19 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 6.24e-04 | 819 | 19 | 5 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 6.35e-04 | 822 | 19 | 5 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.00e-04 | 469 | 19 | 4 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 7.24e-04 | 201 | 19 | 3 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 7.45e-04 | 203 | 19 | 3 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 9.06e-04 | 50 | 19 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.06e-03 | 524 | 19 | 4 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 1.22e-03 | 241 | 19 | 3 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.50e-03 | 259 | 19 | 3 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 2.08e-03 | 76 | 19 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.64e-14 | 136 | 19 | 7 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.64e-14 | 136 | 19 | 7 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.06e-13 | 180 | 19 | 7 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.69e-08 | 197 | 19 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-08 | 198 | 19 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-08 | 198 | 19 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.78e-08 | 199 | 19 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-08 | 200 | 19 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.00e-06 | 184 | 19 | 4 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 184 | 19 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.11e-06 | 189 | 19 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.11e-06 | 189 | 19 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 193 | 19 | 4 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 1.29e-06 | 196 | 19 | 4 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.34e-06 | 198 | 19 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.39e-06 | 200 | 19 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.39e-06 | 200 | 19 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-05 | 108 | 19 | 3 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-05 | 172 | 19 | 3 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 175 | 19 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 178 | 19 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | C_00|World / shred on cell type and cluster | 5.73e-05 | 179 | 19 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 180 | 19 | 3 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 187 | 19 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.52e-05 | 187 | 19 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.62e-05 | 188 | 19 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 189 | 19 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 190 | 19 | 3 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 6.94e-05 | 191 | 19 | 3 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.94e-05 | 191 | 19 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 7.16e-05 | 193 | 19 | 3 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | CV-Severe-2|CV / Virus stimulation, Condition and Cluster | 7.38e-05 | 195 | 19 | 3 | 1cde7f6e6c9c610bacc79014519447112c27dd9d | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 7.49e-05 | 196 | 19 | 3 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 197 | 19 | 3 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.72e-05 | 198 | 19 | 3 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.84e-05 | 199 | 19 | 3 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.84e-05 | 199 | 19 | 3 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 7.84e-05 | 199 | 19 | 3 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 7.84e-05 | 199 | 19 | 3 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 7.84e-05 | 199 | 19 | 3 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | CV-Mild-2|Mild / Virus stimulation, Condition and Cluster | 7.84e-05 | 199 | 19 | 3 | d88cc07053a852e6c468538a0a851ffa09f97a0d | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.84e-05 | 199 | 19 | 3 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 7.96e-05 | 200 | 19 | 3 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 7.96e-05 | 200 | 19 | 3 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.96e-05 | 200 | 19 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.99e-04 | 105 | 19 | 2 | aa9de4333021fa02dd8e8325d0b51bb661dcc678 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.33e-04 | 107 | 19 | 2 | 60b272f5c89bea8a2714f870e18b7ac89a4a4bf6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.33e-04 | 107 | 19 | 2 | c41bc8810df67158f0ae9f6015c965a8ebd96965 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.25e-03 | 124 | 19 | 2 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-03 | 127 | 19 | 2 | 1f9039d2a9e418c41716c3608d4d03574b71904a | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-03 | 128 | 19 | 2 | 4a1f7b76b64df06531db79e427eda084374ce7b5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 1.50e-03 | 136 | 19 | 2 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 145 | 19 | 2 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.84e-03 | 151 | 19 | 2 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 153 | 19 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 153 | 19 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-03 | 162 | 19 | 2 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-03 | 163 | 19 | 2 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.17e-03 | 164 | 19 | 2 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-03 | 164 | 19 | 2 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-03 | 169 | 19 | 2 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-03 | 169 | 19 | 2 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.35e-03 | 171 | 19 | 2 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.35e-03 | 171 | 19 | 2 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-03 | 172 | 19 | 2 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-03 | 172 | 19 | 2 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 173 | 19 | 2 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | critical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.41e-03 | 173 | 19 | 2 | 4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 173 | 19 | 2 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-03 | 173 | 19 | 2 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 173 | 19 | 2 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-03 | 176 | 19 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-03 | 178 | 19 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-03 | 178 | 19 | 2 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.55e-03 | 178 | 19 | 2 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 180 | 19 | 2 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-03 | 182 | 19 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.66e-03 | 182 | 19 | 2 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-03 | 182 | 19 | 2 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-03 | 182 | 19 | 2 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-03 | 183 | 19 | 2 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-03 | 183 | 19 | 2 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-03 | 184 | 19 | 2 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.72e-03 | 184 | 19 | 2 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 185 | 19 | 2 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 185 | 19 | 2 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 185 | 19 | 2 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-03 | 186 | 19 | 2 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-03 | 186 | 19 | 2 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-03 | 186 | 19 | 2 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-03 | 188 | 19 | 2 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.83e-03 | 188 | 19 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-03 | 189 | 19 | 2 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-03 | 189 | 19 | 2 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-03 | 190 | 19 | 2 | c6709b6cb518c569d06fb234a0e3b0434ef08392 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-03 | 190 | 19 | 2 | 8ce836bd45634b668a87e2b8d49ccaf1e43e003e | |
| Computational | Neighborhood of DDX5 | 1.98e-08 | 65 | 15 | 5 | GCM_DDX5 | |
| Computational | Neighborhood of SMARCC1 | 1.58e-07 | 37 | 15 | 4 | GCM_SMARCC1 | |
| Computational | Neighborhood of DENR | 5.90e-07 | 51 | 15 | 4 | GNF2_DENR | |
| Computational | Neighborhood of GNB1 | 2.00e-06 | 305 | 15 | 6 | MORF_GNB1 | |
| Computational | Neighborhood of APEX1 | 6.38e-06 | 92 | 15 | 4 | GNF2_APEX1 | |
| Computational | Neighborhood of ACP1 | 7.11e-06 | 211 | 15 | 5 | MORF_ACP1 | |
| Computational | Neighborhood of UBE2N | 7.25e-06 | 95 | 15 | 4 | MORF_UBE2N | |
| Computational | Genes in the cancer module 32. | 1.36e-05 | 241 | 15 | 5 | MODULE_32 | |
| Computational | Neighborhood of APEX1 | 1.50e-05 | 114 | 15 | 4 | GCM_APEX1 | |
| Computational | Neighborhood of HDAC1 | 1.75e-05 | 254 | 15 | 5 | MORF_HDAC1 | |
| Computational | Neighborhood of DEK | 2.11e-05 | 264 | 15 | 5 | MORF_DEK | |
| Computational | Neighborhood of RAF1 | 2.62e-05 | 43 | 15 | 3 | GCM_RAF1 | |
| Computational | Neighborhood of ELAC2 | 3.22e-05 | 46 | 15 | 3 | GNF2_ELAC2 | |
| Computational | Neighborhood of CDC10 | 3.97e-05 | 146 | 15 | 4 | MORF_CDC10 | |
| Computational | Neighborhood of SMC1L1 | 7.91e-05 | 62 | 15 | 3 | MORF_SMC1L1 | |
| Computational | RNA splicing. | 9.12e-05 | 65 | 15 | 3 | MODULE_183 | |
| Computational | Neighborhood of TERF1 | 9.98e-05 | 67 | 15 | 3 | MORF_TERF1 | |
| Computational | Neighborhood of CBFB | 1.14e-04 | 70 | 15 | 3 | GCM_CBFB | |
| Computational | Neighborhood of RBBP6 | 1.14e-04 | 70 | 15 | 3 | GNF2_RBBP6 | |
| Computational | Neighborhood of XRCC5 | 2.51e-04 | 235 | 15 | 4 | MORF_XRCC5 | |
| Computational | Neighborhood of HDAC1 | 4.34e-04 | 110 | 15 | 3 | GNF2_HDAC1 | |
| Computational | Neighborhood of DAP3 | 5.46e-04 | 119 | 15 | 3 | GNF2_DAP3 | |
| Computational | Neighborhood of ACTG1 | 6.16e-04 | 124 | 15 | 3 | GCM_ACTG1 | |
| Computational | Neighborhood of MSN | 6.73e-04 | 28 | 15 | 2 | GCM_MSN | |
| Computational | Neighborhood of TPR | 8.80e-04 | 32 | 15 | 2 | GCM_TPR | |
| Computational | Neighborhood of FBL | 9.91e-04 | 146 | 15 | 3 | GNF2_FBL | |
| Computational | Neighborhood of TDG | 1.05e-03 | 35 | 15 | 2 | GNF2_TDG | |
| Computational | Neighborhood of RAD23A | 1.11e-03 | 348 | 15 | 4 | MORF_RAD23A | |
| Computational | Neighborhood of ANP32B | 1.11e-03 | 36 | 15 | 2 | GCM_ANP32B | |
| Computational | Neighborhood of RAD21 | 1.18e-03 | 37 | 15 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of HDAC1 | 1.24e-03 | 38 | 15 | 2 | GCM_HDAC1 | |
| Computational | Neighborhood of G22P1 | 1.59e-03 | 172 | 15 | 3 | MORF_G22P1 | |
| Computational | Neighborhood of MYST2 | 1.59e-03 | 172 | 15 | 3 | GCM_MYST2 | |
| Computational | Neighborhood of HAT1 | 1.67e-03 | 175 | 15 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of VAV1 | 1.89e-03 | 47 | 15 | 2 | GCM_VAV1 | |
| Computational | Neighborhood of ANP32B | 2.38e-03 | 198 | 15 | 3 | MORF_ANP32B | |
| Computational | Neighborhood of BAG5 | 2.59e-03 | 55 | 15 | 2 | MORF_BAG5 | |
| Computational | Neighborhood of DEK | 2.87e-03 | 58 | 15 | 2 | GNF2_DEK | |
| Computational | Neighborhood of SNRP70 | 3.28e-03 | 62 | 15 | 2 | MORF_SNRP70 | |
| Computational | Neighborhood of BECN1 | 3.93e-03 | 68 | 15 | 2 | GCM_BECN1 | |
| Computational | Neighborhood of UBE2I | 4.00e-03 | 238 | 15 | 3 | MORF_UBE2I | |
| Computational | Neighborhood of HBP1 | 4.16e-03 | 70 | 15 | 2 | GCM_HBP1 | |
| Computational | Neighborhood of EIF3S2 | 4.39e-03 | 246 | 15 | 3 | MORF_EIF3S2 | |
| Computational | Neighborhood of KPNB1 | 4.51e-03 | 73 | 15 | 2 | GNF2_KPNB1 | |
| Computational | Neighborhood of XRCC5 | 4.76e-03 | 75 | 15 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of BMI1 | 5.53e-03 | 81 | 15 | 2 | MORF_BMI1 | |
| Computational | Neighborhood of RAN | 5.58e-03 | 268 | 15 | 3 | MORF_RAN | |
| Computational | Neighborhood of PCNA | 5.79e-03 | 83 | 15 | 2 | MORF_PCNA | |
| Computational | Neighborhood of BUB3 | 6.12e-03 | 277 | 15 | 3 | MORF_BUB3 | |
| Computational | Neighborhood of CCNI | 6.49e-03 | 88 | 15 | 2 | MORF_CCNI | |
| Computational | Neighborhood of CSNK2B | 6.75e-03 | 287 | 15 | 3 | MORF_CSNK2B | |
| Computational | Transcription. | 7.68e-03 | 96 | 15 | 2 | MODULE_124 | |
| Computational | Genes in the cancer module 198. | 7.85e-03 | 303 | 15 | 3 | MODULE_198 | |
| Computational | Neighborhood of CSNK2B | 8.15e-03 | 99 | 15 | 2 | GCM_CSNK2B | |
| Computational | Neighborhood of PTPN11 | 9.64e-03 | 108 | 15 | 2 | MORF_PTPN11 | |
| Computational | Neighborhood of DNMT1 | 1.14e-02 | 118 | 15 | 2 | MORF_DNMT1 | |
| Computational | Genes in the cancer module 14. | 1.23e-02 | 357 | 15 | 3 | MODULE_15 | |
| Computational | Neighborhood of DFFA | 1.35e-02 | 129 | 15 | 2 | GCM_DFFA | |
| Computational | Neighborhood of IKBKG | 1.52e-02 | 137 | 15 | 2 | MORF_IKBKG | |
| Computational | Neighborhood of EIF4A2 | 1.54e-02 | 138 | 15 | 2 | MORF_EIF4A2 | |
| Computational | Neighborhood of FBL | 1.58e-02 | 140 | 15 | 2 | MORF_FBL | |
| Computational | Genes in the cancer module 98. | 1.59e-02 | 393 | 15 | 3 | MODULE_98 | |
| Drug | AC1L1AUZ | 3.05e-11 | 157 | 19 | 7 | CID000001160 | |
| Drug | AC1NRA5C | 6.29e-11 | 174 | 19 | 7 | CID005287709 | |
| Drug | bromovanin | 3.35e-06 | 127 | 19 | 4 | ctd:C515564 | |
| Drug | testosterone enanthate | 5.18e-06 | 575 | 19 | 6 | ctd:C004648 | |
| Drug | 14-deoxy-11,12-didehydroandrographolide | 1.19e-05 | 175 | 19 | 4 | ctd:C495626 | |
| Drug | DAPH2 | 1.48e-05 | 58 | 19 | 3 | CID006711154 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; HL60; HG-U133A | 1.76e-05 | 193 | 19 | 4 | 1774_DN | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.76e-05 | 193 | 19 | 4 | 6587_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; HL60; HG-U133A | 1.83e-05 | 195 | 19 | 4 | 1985_DN | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.87e-05 | 196 | 19 | 4 | 6902_DN | |
| Drug | AC1L1B55 | 2.85e-05 | 454 | 19 | 5 | CID000001287 | |
| Drug | AsF3 | 3.61e-05 | 11 | 19 | 2 | CID000024571 | |
| Drug | tamibarotene | 1.04e-04 | 596 | 19 | 5 | ctd:C061133 | |
| Drug | poly(G | 1.12e-04 | 114 | 19 | 3 | CID000439502 | |
| Drug | potassium hydride | 1.57e-04 | 128 | 19 | 3 | CID000082127 | |
| Drug | genistein | 2.15e-04 | 1117 | 19 | 6 | CID005280961 | |
| Drug | Vincristine | 2.92e-04 | 1182 | 19 | 6 | ctd:D014750 | |
| Drug | A-skin | 3.22e-04 | 32 | 19 | 2 | CID000208772 | |
| Drug | EMCs | 3.64e-04 | 34 | 19 | 2 | CID005091655 | |
| Drug | kojic acid | 3.68e-04 | 424 | 19 | 4 | ctd:C011890 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.15e-04 | 178 | 19 | 3 | 3998_DN | |
| Drug | Succimer | 4.20e-04 | 1264 | 19 | 6 | ctd:D004113 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.22e-04 | 179 | 19 | 3 | 4585_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.50e-04 | 183 | 19 | 3 | 7498_DN | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; HL60; HG-U133A | 4.57e-04 | 184 | 19 | 3 | 1565_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.65e-04 | 185 | 19 | 3 | 1673_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 4.72e-04 | 186 | 19 | 3 | 2353_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.80e-04 | 187 | 19 | 3 | 4302_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.95e-04 | 189 | 19 | 3 | 4271_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.02e-04 | 190 | 19 | 3 | 4507_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A | 5.02e-04 | 190 | 19 | 3 | 1974_DN | |
| Drug | Magnetite Nanoparticles | 5.08e-04 | 1310 | 19 | 6 | ctd:D058185 | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; HL60; HG-U133A | 5.10e-04 | 191 | 19 | 3 | 1613_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.10e-04 | 191 | 19 | 3 | 4269_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 5.18e-04 | 192 | 19 | 3 | 4268_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 6835_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; HL60; HG-U133A | 5.26e-04 | 193 | 19 | 3 | 2015_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; HL60; HG-U133A | 5.34e-04 | 194 | 19 | 3 | 1610_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; HL60; HG-U133A | 5.34e-04 | 194 | 19 | 3 | 1988_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 4612_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 5620_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 2293_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 1330_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 5.42e-04 | 195 | 19 | 3 | 1561_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 5857_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 5.50e-04 | 196 | 19 | 3 | 1790_DN | |
| Drug | PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6563_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A | 5.50e-04 | 196 | 19 | 3 | 1423_DN | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6905_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 3847_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 4613_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2547_DN | |
| Drug | genistein; Down 200; 10uM; PC3; HG-U133A | 5.58e-04 | 197 | 19 | 3 | 703_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 4266_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; HL60; HG-U133A | 5.66e-04 | 198 | 19 | 3 | 2026_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; HL60; HG-U133A | 5.66e-04 | 198 | 19 | 3 | 1621_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; HL60; HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2024_DN | |
| Drug | Demecolcine | 6.24e-04 | 878 | 19 | 5 | ctd:D003703 | |
| Drug | rare-earth | 6.39e-04 | 45 | 19 | 2 | CID004232365 | |
| Drug | 2-(ethylsulfonyl)ethanol | 6.72e-04 | 210 | 19 | 3 | CID000010549 | |
| Drug | 4-PBA | 8.10e-04 | 224 | 19 | 3 | CID000004775 | |
| Drug | pelargonic acid | 8.21e-04 | 51 | 19 | 2 | ctd:C008776 | |
| Drug | oxybenzone | 8.53e-04 | 52 | 19 | 2 | ctd:C005290 | |
| Drug | reverse T | 1.06e-03 | 58 | 19 | 2 | CID000064973 | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 1.05e-06 | 3 | 18 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.31e-05 | 12 | 18 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.51e-04 | 30 | 18 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 3.65e-04 | 1074 | 18 | 5 | C0006142 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.69e-04 | 58 | 18 | 2 | C0002736 | |
| Disease | Global developmental delay | 2.94e-03 | 133 | 18 | 2 | C0557874 | |
| Disease | Mammary Neoplasms, Human | 3.75e-03 | 525 | 18 | 3 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 3.75e-03 | 525 | 18 | 3 | C4704874 | |
| Disease | Mammary Neoplasms | 3.79e-03 | 527 | 18 | 3 | C1458155 | |
| Disease | Breast Carcinoma | 4.01e-03 | 538 | 18 | 3 | C0678222 | |
| Disease | Disease Exacerbation | 4.48e-03 | 165 | 18 | 2 | C0235874 | |
| Disease | urinary albumin to creatinine ratio | 5.25e-03 | 179 | 18 | 2 | EFO_0007778 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.37e-03 | 181 | 18 | 2 | DOID:684 (is_implicated_in) | |
| Disease | Seizures | 7.69e-03 | 218 | 18 | 2 | C0036572 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.35e-02 | 293 | 18 | 2 | C1708349 | |
| Disease | Stomach Neoplasms | 1.39e-02 | 297 | 18 | 2 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.42e-02 | 300 | 18 | 2 | C0024623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGGRGYLAYTGLGRG | 396 | Q9NQ94 | |
| RYGGPGGGERARGGG | 11 | Q00975 | |
| RGPANGFRGGYDGYR | 626 | Q14444 | |
| GYGGSQGGGRGRGGY | 176 | Q92804 | |
| GGDFRGRGYGGERGY | 391 | Q92804 | |
| GRGYGGERGYRGRGG | 396 | Q92804 | |
| YGGDRSGGGYGGDRG | 446 | Q92804 | |
| GGYGGDRGGGYGGDR | 461 | Q92804 | |
| DRGGGYGGDRGGGYG | 466 | Q92804 | |
| YGGDRGGGYGGDRGG | 471 | Q92804 | |
| GGGYGGDRGGYGGDR | 476 | Q92804 | |
| GDRGGYGGDRGGGYG | 481 | Q92804 | |
| YGGDRGGGYGGDRGG | 486 | Q92804 | |
| GGGYGGDRGGYGGDR | 491 | Q92804 | |
| GDRGGYGGDRGGYGG | 496 | Q92804 | |
| GGYGGDRGGYGGDRG | 506 | Q92804 | |
| DRGGYGGDRGGYGGD | 511 | Q92804 | |
| GYGGDRSRGGYGGDR | 521 | Q92804 | |
| YGGDRGGGSGYGGDR | 531 | Q92804 | |
| GGYGGDRGGGYGGDR | 556 | Q92804 | |
| DRGGGYGGDRGGYGG | 561 | Q92804 | |
| YGGDRGGYGGKMGGR | 566 | Q92804 | |
| GGYAPYGRPGRGLRA | 166 | Q14526 | |
| RGRGRRGPNYTSGYG | 386 | P51114 | |
| DRRGGRGGYDRGGYR | 471 | P35637 | |
| RGGYDRGGYRGRGGD | 476 | P35637 | |
| RGGYRGRGGDRGGFR | 481 | P35637 | |
| PPTRGRGRGGRGGYG | 441 | O60506 | |
| RGRGGRGGYGYPPDY | 446 | O60506 | |
| IRGRGRGGGRGGYGY | 446 | O43390 | |
| RPIGGRGGYYGAGRG | 116 | P31942 | |
| RGRGYYQGGGGRYHR | 76 | Q9NYF8 | |
| YQGGGGRYHRGGYRP | 81 | Q9NYF8 | |
| RGGYGGRGGYGGRGY | 396 | Q52LJ0 | |
| RYYGGGSEGGRAPKR | 46 | P14866 | |
| GPREGYGGFRGQREG | 716 | Q9NR30 | |
| GFRGRGGGGGFQRYE | 616 | Q9BUJ2 | |
| PPRRYGGGGYGRRSR | 106 | Q01130 | |
| RGRSYRGSYGGRGRG | 1196 | Q9Y520 | |
| GGGGGGRRRDSYYDR | 226 | Q13595 | |
| GGGYGGGRSYRGGGA | 516 | Q7Z794 |